In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
RAPT Therapeutics Inc (NASDAQ: RAPT) closed the day trading at $7.80 down -1.27% from the previous closing price of $7.90. In other words, the price has decreased by -$1.27 from its previous closing price. On the day, 0.42 million shares were traded. RAPT stock price reached its highest trading level at $7.915 during the session, while it also had its lowest trading level at $7.52.
Ratios:
For a better understanding of RAPT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 22, 2024, Downgraded its rating to Neutral and sets its target price to $10 from $61 previously.
On February 21, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $42 to $10.
JP Morgan Downgraded its Overweight to Neutral on February 21, 2024, whereas the target price for the stock was revised from $35 to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.
HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share. On Nov 28 ’23, another insider, HO WILLIAM, who serves as the Chief Medical Officer of the company, sold 1,500 shares for $13.72 each. As a result, the insider received 20,580 and left with 17,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 274918016 and an Enterprise Value of 119466072.
Stock Price History:
Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $6.86. The 50-Day Moving Average of the stock is -21.17%, while the 200-Day Moving Average is calculated to be -53.74%.
Shares Statistics:
Over the past 3-months, RAPT traded about 1.35M shares per day on average, while over the past 10 days, RAPT traded about 761080 shares per day. A total of 34.40M shares are outstanding, with a floating share count of 30.64M. Insiders hold about 11.96% of the company’s shares, while institutions hold 90.51% stake in the company. Shares short for RAPT as of 1713139200 were 3184129 with a Short Ratio of 2.36, compared to 1710460800 on 3297629. Therefore, it implies a Short% of Shares Outstanding of 3184129 and a Short% of Float of 12.3100005.
